Northside Capital Management LLC Acquires New Holdings in Stryker Corporation $SYK

Key Points

• Northside Capital Management LLC acquired 900 shares of Stryker Corporation, valued at approximately $356,000, as reported in its latest 13F filing with the SEC.
• Several institutional investors, including Brighton Jones LLC and Ameriflex Group Inc., have also increased their holdings in Stryker, indicating a broader interest in the company.
• Stryker recently announced a quarterly dividend of $0.84 per share, set to be paid on October 31st, reflecting a 0.9% dividend yield and a payout ratio of 44.50%.

Northside Capital Management LLC acquired a new stake in shares of Stryker Corporation (NYSE:SYK - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 900 shares of the medical technology company's stock, valued at approximately $356,000.

Several other institutional investors and hedge funds have also modified their holdings of SYK. Brighton Jones LLC grew its position in shares of Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company's stock valued at $1,643,000 after purchasing an additional 609 shares during the period. Ameriflex Group Inc. acquired a new position in shares of Stryker in the 4th quarter valued at approximately $95,000. Integrated Advisors Network LLC grew its position in shares of Stryker by 5.5% in the 4th quarter. Integrated Advisors Network LLC now owns 3,415 shares of the medical technology company's stock valued at $1,230,000 after purchasing an additional 178 shares during the period. Capital A Wealth Management LLC acquired a new position in shares of Stryker in the 4th quarter valued at approximately $26,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Stryker in the 4th quarter valued at approximately $154,140,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Viju Menon sold 500 shares of the company's stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $390.61, for a total transaction of $195,305.00. Following the sale, the insider owned 12,511 shares in the company, valued at $4,886,921.71. This represents a 3.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Ronda E. Stryker sold 200,000 shares of the company's stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the sale, the director owned 3,222,108 shares in the company, valued at approximately $1,212,962,556.60. This represents a 5.84% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 5.20% of the company's stock.

Stryker Trading Down 1.3%

Shares of Stryker stock opened at $373.12 on Wednesday. Stryker Corporation has a 12-month low of $329.16 and a 12-month high of $406.19. The stock has a market cap of $142.65 billion, a P/E ratio of 49.42, a P/E/G ratio of 2.72 and a beta of 0.93. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The business's 50 day moving average is $386.91 and its 200-day moving average is $379.01.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.07 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The company had revenue of $6.02 billion for the quarter, compared to analysts' expectations of $5.92 billion. During the same quarter in the prior year, the business posted $2.81 EPS. The business's revenue was up 11.1% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Equities research analysts predict that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.84 per share. The ex-dividend date is Tuesday, September 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.9%. Stryker's dividend payout ratio is currently 44.50%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on SYK shares. Rothschild Redb upgraded Stryker to a "hold" rating in a research report on Thursday, September 18th. Truist Financial set a $415.00 price target on Stryker and gave the stock a "hold" rating in a research report on Monday, August 4th. Evercore ISI upped their price target on Stryker from $390.00 to $415.00 and gave the stock an "outperform" rating in a research report on Tuesday, July 8th. Wells Fargo & Company upped their price target on Stryker from $435.00 to $445.00 and gave the stock an "overweight" rating in a research report on Friday, August 1st. Finally, BTIG Research reaffirmed a "buy" rating on shares of Stryker in a research report on Monday, July 14th. Fourteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, Stryker currently has an average rating of "Moderate Buy" and a consensus price target of $430.33.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.